Friday, July 13, 2012

Could Increase The Risk Of Diabetes Drug Bladder Kanker

Could Increase The Risk Of Diabetes Drug Bladder Kanker - Drugs commonly prescribed to type 2 diabetes, pioglitazone, it can improve risk bladder Kancer.
According to recent research conducted researchers from canada. In an effort to connect pioglitazone and bladder cancer, researchers perform systematic review and analysis of these clinical trials and observational studies involving from 2.6 million more patient.
The " we observe increased risk bladder cancer, associated with use thiazolidinediones the " wrote jeffrey jonhson of school of public health, university of alberta in medical association canada journal.
For your information, thiazolidinediones including pioglitazone introduced in the late 1990s, glitazones, also known as a class of drugs used in treating type 2 diabetes.
The " specifically, use pioglitazone associated with increased risk bladder cancer based on estimation so obtained from three kohort studies involving more than 1.7 million people the " added johnson.
The researchers also see possible link with rosiglitazone, other kinds of thiazolidinedione, but not seen the effect.

No comments:

Post a Comment

Listing The Contents